Smiles: OC([C@H]1O)[C@H](OC2O[C@H](CSCCC(O)=O)[C@@H](O3)[C@@H](O)[C@H]2O)[C@@H](CSCCC(O)=O)O[C@@H]1O[C@@H]([C@@H](O)[C@H]4OP(O)(O)=O)[C@@H](CSCCC(O)=O)OC4O[C@H]([C@H](O)[C@@H]5O)[C@H](CS(CCC(O)=O)=O)OC5O[C@H](C(O)[C@@H]6O)[C@H](CSCCC(O)=O)O[C@H]6O[C@H](C(O)[C@@H]7O)[C@H](CSCCC(O)=O)O[C@H]7O[C@H](C(O)[C@@H]8O)[C@H](CSCCC(O)=O)O[C@H]8O[C@@H]9[C@@H](CSCCC(O)=O)O[C@@H]3[C@H](O)C9O
Inchi: InChI=1S/C69H106O46S7/c70-31(71)1-8-116-16-24-54-38(84)45(91)62(101-24)108-53-23-15-99-61(52(53)98)69(100-23)115-60-30(22-122-14-7-37(82)83)107-68(51(97)44(60)90)114-59-29(21-121-13-6-36(80)81)106-67(50(96)43(59)89)113-58-28(20-120-12-5-35(78)79)105-66(49(95)42(58)88)112-57-27(19-119-11-4-34(76)77)104-65(48(94)41(57)87)111-56-26(18-118-10-3-33(74)75)103-64(47(93)40(56)86)110-55-25(17-117-9-2-32(72)73)102-63(109-54)46(92)39(55)85/h23-30,38-69,84-98H,1-22H2,(H,70,71)(H,72,73)(H,74,75)(H,76,77)(H,78,79)(H,80,81)(H,82,83)/t23-,24+,25+,26+,27+,28-,29-,30-,38-,39?,40-,41?,42?,43?,44?,45+,46+,47+,48+,49-,50-,51-,52-,53-,54+,55+,56+,57+,58-,59-,60-,61-,62?,63+,64?,65-,66-,67-,68-,69?/m0/s1
Analytical method development and validation for the estimation of sugammadex
By Parekh, Hemangi; Chokshi, Parin; Mashru, Rajashree
From Journal of Drug Delivery and Therapeutics (2020), 10(1), 52-59.
Determination of sugammadex in human plasma, urine, and dialysate using a high-performance liquid chromatography/tandem mass spectrometry assay
By de Zwart Marcel A H; ten Bruggencate-Broeders Jolanda; van Hal Henk J M; Megens Rene H J J J; Frasa Helma W L H
From Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (2011), 879(19), 1573-86.